Mathias Abegg1, Muriel Dysli2, Sebastian Wolf2, Jens Kowal3, Pascal Dufour3, Martin Zinkernagel2. 1. Department of Ophthalmology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. Electronic address: mathias.abegg@insel.ch. 2. Department of Ophthalmology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. 3. ARTORG Center for Biomedical Engineering Research, University of Bern, Bern, Switzerland.
Abstract
PURPOSE: To investigate retrograde axonal degeneration for its potential to cause microcystic macular edema (MME), a maculopathy that has been previously described in patients with demyelinating disease. To identify risk factors for MME and to expand the anatomic knowledge on MME. DESIGN: Retrospective case series. PARTICIPANTS: We included 117 consecutive patients and 180 eyes with confirmed optic neuropathy of variable etiology. Patients with glaucoma were excluded. METHODS: We determined age, sex, visual acuity, etiology of optic neuropathy, and the temporal and spatial characteristics of MME. Eyes with MME were compared with eyes with optic neuropathy alone and to healthy fellow eyes. With retinal layer segmentation we quantitatively measured the intraretinal anatomy. MAIN OUTCOME MEASURES: Demographic data, distribution of MME in the retina, and thickness of retinal layers were analyzed. RESULTS: We found MME in 16 eyes (8.8%) from 9 patients, none of whom had multiple sclerosis or neuromyelitis optica. The MME was restricted to the inner nuclear layer (INL) and had a characteristic perifoveal circular distribution. Compared with healthy controls, MME was associated with significant thinning of the ganglion cell layer and nerve fiber layer, as well as a thickening of the INL and the deeper retinal layers. Youth is a significant risk factor for MME. CONCLUSIONS: Microcystic macular edema is not specific for demyelinating disease. It is a sign of optic neuropathy irrespective of its etiology. The distinctive intraretinal anatomy suggests that MME is caused by retrograde degeneration of the inner retinal layers, resulting in impaired fluid resorption in the macula.
PURPOSE: To investigate retrograde axonal degeneration for its potential to cause microcystic macular edema (MME), a maculopathy that has been previously described in patients with demyelinating disease. To identify risk factors for MME and to expand the anatomic knowledge on MME. DESIGN: Retrospective case series. PARTICIPANTS: We included 117 consecutive patients and 180 eyes with confirmed optic neuropathy of variable etiology. Patients with glaucoma were excluded. METHODS: We determined age, sex, visual acuity, etiology of optic neuropathy, and the temporal and spatial characteristics of MME. Eyes with MME were compared with eyes with optic neuropathy alone and to healthy fellow eyes. With retinal layer segmentation we quantitatively measured the intraretinal anatomy. MAIN OUTCOME MEASURES: Demographic data, distribution of MME in the retina, and thickness of retinal layers were analyzed. RESULTS: We found MME in 16 eyes (8.8%) from 9 patients, none of whom had multiple sclerosis or neuromyelitis optica. The MME was restricted to the inner nuclear layer (INL) and had a characteristic perifoveal circular distribution. Compared with healthy controls, MME was associated with significant thinning of the ganglion cell layer and nerve fiber layer, as well as a thickening of the INL and the deeper retinal layers. Youth is a significant risk factor for MME. CONCLUSIONS:Microcystic macular edema is not specific for demyelinating disease. It is a sign of optic neuropathy irrespective of its etiology. The distinctive intraretinal anatomy suggests that MME is caused by retrograde degeneration of the inner retinal layers, resulting in impaired fluid resorption in the macula.
Authors: Omar Al-Louzi; Elias S Sotirchos; Angela Vidal-Jordana; Shin C Beh; Julia Button; Howard S Ying; Laura J Balcer; Elliot M Frohman; Shiv Saidha; Peter A Calabresi; Scott D Newsome Journal: Mult Scler Date: 2017-11-10 Impact factor: 6.312
Authors: Gema Rebolleda; Laura Diez-Alvarez; Alfonso Casado; Carmen Sánchez-Sánchez; Elisabet de Dompablo; Julio J González-López; Francisco J Muñoz-Negrete Journal: Saudi J Ophthalmol Date: 2014-10-05
Authors: Joachim Havla; T Kümpfel; R Schinner; M Spadaro; E Schuh; E Meinl; R Hohlfeld; O Outteryck Journal: J Neurol Date: 2016-11-14 Impact factor: 4.849
Authors: Adam L Rothman; Du Tran-Viet; Kathryn E Gustafson; Ricki F Goldstein; Maureen G Maguire; Vincent Tai; Neeru Sarin; Amy Y Tong; Jiayan Huang; Laura Kupper; C Michael Cotten; Sharon F Freedman; Cynthia A Toth Journal: Ophthalmology Date: 2014-11-04 Impact factor: 12.079
Authors: Bhavna J Antony; Andrew Lang; Emily K Swingle; Omar Al-Louzi; Aaron Carass; Sharon Solomon; Peter A Calabresi; Shiv Saidha; Jerry L Prince Journal: Proc SPIE Int Soc Opt Eng Date: 2016-03-21
Authors: Axel Petzold; Mike P Wattjes; Fiona Costello; Jose Flores-Rivera; Clare L Fraser; Kazuo Fujihara; Jacqueline Leavitt; Romain Marignier; Friedemann Paul; Sven Schippling; Christian Sindic; Pablo Villoslada; Brian Weinshenker; Gordon T Plant Journal: Nat Rev Neurol Date: 2014-07-08 Impact factor: 42.937